Diminished Th1-like response to autoantigens in children with a high risk of developing type 1 diabetes

Scandinavian Journal of Immunology

Volumn 61, Issue 2, 2005, Pages 173-179

  Karlsson Faresjo M G E ^a   Ludvigsson, J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE 65; INSULIN; INTERLEUKIN 4; PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENDER; HIGH RISK PATIENT; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NORMAL HUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; AUTOANTIGENS; C-REACTIVE PROTEIN; CHILD; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NIACINAMIDE; PREDIABETIC STATE; PROINSULIN; PROTEIN-TYROSINE-PHOSPHATASE; TH1 CELLS; TH2 CELLS;

EID: 13844297163     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2005.01544.x     Document Type: Article

References (27)

1. Castano L, Eisenbarth GS. Type I diabetes. A chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 1990;8:647-79.
2. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985;313:353-60.
3. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993;366:72-5.
4. Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? Diabetes 1994;43:613-21.
5. Kallmann BA, Hüther M, Tubes M et al. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes 1997;46:237-43.
6. Baekkeskov S, Aanstoot H-J, Christgau S et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990;347:151-6.
7. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995;16:34-8.
8. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994;94:2125-9.
9. Karlsson MGE, Ludvigsson J. Peptide from glutamic acid decarboxylase similar to coxsackie B virus stimulates IFN-γ mRNA expression in Th1-like lymphocytes from children with recent-onset insulin-dependent diabetes mellitus. Acta Diabetol 1998;35:137-44.
10. Durinovic-Belló I, Hummel M, Ziegler AG. Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 1996;45:795-800.
11. Ellis TM, Schatz DA, Ottendorfer EW et al. The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes 1998;47:566-9.
12. Harrison LC, Chu SX, DeAizpurua HJ, Graham M, Honeyman MC, Cloman PG. Islet-reactive T-cells are a marker of preclinical insulin-dependent diabetes. J Clin Invest 1992;89:1161-5.
13. Schloot NC, Roep BO, Wegmann D et al. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia 1997;40:564-72.
14. Song YH, Li Y, Maclaren NK. The nature of autoantigens targeted in autoimmune endocrine diseases. Immunol Today 1996;17:232-8.
15. Halminen M, Simell O, Knip M, Ilonen J. Cytokine expression in unstimulated PBMC of children with type 1 diabetes and subjects positive for diabetes-associated antibodies. Scand J Immunol 2001;53:510-3.
16. Mayer AF, Rharbaoui C, Thivolet J, Orgiazzi J, Madec AM. The relationship between peripheral T cell reactivity to insulin, clinical remissions and cytokine production in type 1 (insulin-dependent) diabetes mellitus. J Endocrinol Metab 1999;84:2419-24.
17. Kukreja A, Cost G, Marker J et al. Multiple immune-regulatory defects in type-1 diabetes. J Clin Invest 2002;1:131-40.
18. Karlsson Faresjö M, Ernerudh E, Ludvigsson J. Cytokine profile in children during the first 3 months after the diagnosis of type 1 diabetes. Scand J Immunol 2004;59:517-26.
19. Karlsson MGE, Sederholm Lawesson S, Ludvigsson J. Th1-like dominance in high-risk first-degree relatives of type 1 diabetic patients. Diabetologia 2000;43:742-9.
20. Schloot NC, Meierhoff G, Karlsson Faresjö M et al. Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report of the Third Immunology of Diabetes Society T-cell Workshop. J Autoimmunity 2003;21:365-76.
21. Wahlberg J, Fredriksson J, Vaarala O, Ludvigsson J, group for the ABIS Study Group. Vaccinations may induce diabetes-related auto-antibodies in one-year-old children. Ann N Y Acad Sci 2003;1005:404-8.
22. Lohmann T, Laue S, Nietzschmann U et al. Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes. Diabetes 2002;51:2474-80.
23. Douglas Petersen L, Van der Keur M, de Vires RRP, Roep BO. Autoreactive and immunoregulatory T-cell subsets in insulin dependent diabetes mellitus. Diabetologia 1999;42:443-9.
24. Wicker LS, Chen SL, Nepom GT et al. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest 1996;98:2597-603.
25. Petrovsky N, Silva D, Schatz DA. Prospects for the prevention and reversal of type 1 diabetes mellitus. Drugs 2002;62:2617-35.
26. Gale EAM. Nicotinamide: Potential for the prevention of type 1 diabetes? Horm Metab Res 1996;28:361-4.
27. Kretowski A, Mysliwiec J, Szelachowska M, Kinalski M, Kinalska I. Nicotinamide inhibits enhanced in vitro production of interleukin-12 and tumor necrosis factor-α in peripheral whole blood of people at high risk of developing type 1 diabetes and people with newly diagnosed type 1 diabetes. Diabetes Res Clin Pract 2000;47:81-6.